Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118164892A details a novel palladium-catalyzed route for 3-alkynyl indoles. This method offers significant supply chain reliability and cost reduction advantages for pharmaceutical manufacturing.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Novel palladium-catalyzed carbonylation for indole-3-carboxamide. Efficient, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN117164506B reveals efficient palladium-catalyzed carbonylation. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN112125856A details a Pd-catalyzed carbonylation route for 2-CF3 quinazolinones, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel transition-metal-free synthesis of benzothienopyridines via nitrile cyclization. High atom economy, scalable process for API intermediates.
Patent CN113735778B reveals efficient silver oxide promoted route. Delivers high purity intermediates with scalable cost reduction for global supply chains.
Patent CN115960142A discloses a one-pot synthesis of osmium heterocycles enabling high-yield hydrosilylation under air, offering cost-effective solutions for fine chemical manufacturing.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one compounds, offering high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Efficient Pd-catalyzed synthesis of 2-pyridinecarboxamide diaryl ketones. High purity pharma intermediates with scalable routes for cost-effective manufacturing.
Patent CN110183378A details a copper-catalyzed route for high-purity pharmaceutical intermediates. This method offers significant cost reduction and supply chain reliability for global buyers.
Novel metal-free route for trifluoromethyl pyrazoles. Room temperature reaction ensures cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for quinoline-4(1H)-one. Enhances supply chain reliability and reduces manufacturing costs for pharma intermediates.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and streamlined supply chains.
Novel glucose-based route for trifluoromethyl triazoles offering cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN114773242A reveals a novel nickel-catalyzed route for alpha,beta-unsaturated thioesters, offering significant cost reduction and supply chain reliability for pharma intermediates.
Patent CN113683595B reveals sulfur-promoted synthesis for high-purity triazole intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturing.
Patent CN116640146B details a novel Pd-catalyzed route for trifluoromethyl chromone quinoline intermediates offering scalable production and cost efficiency for pharmaceutical supply chains.
Novel Pd-catalyzed tandem cyclization method offers mild conditions and high atom economy for complex heterocyclic pharmaceutical intermediates.